slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 91,681-91,710
Pages 3,685
Rows per page 30
Component
91,681-91,710 of 110,539
12
Hyzon | Results Presentation Deck | 15 slidesHyzon | Results Presentation Deck | 15 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
13
The slide title mentions 2024 guidance, but the table headers only show 2H 2023 and FY 2023. The fourth bullet point clarifies the 2024 cash burn guidance.Hyzon | Results Presentation Deck | 15 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
12
The chart shows revenue growth for cohorts starting in FY19-FY23, with Year 2 and Year 3 data for recent cohorts being estimates.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Rising Success1 hit
13
The chart uses a trend arrow to emphasize the CAGR.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
14
The bar chart shows a clear trend of decreasing US revenue and increasing Offshore/Nearshore revenue over 2021-2023.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
17
IBEX | Investor Presentation Deck | 18 slidesIBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
05
The chart shows revenue performance for cohorts starting in FY19-FY23, with Year 2 and Year 3 data points for recent cohorts being estimates.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · Need1 hit
06
The chart highlights a 68% CAGR for BPO 2.0 clients.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · Need1 hit
08
IBEX | Results Presentation Deck | 25 slidesIBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
Includes footnote regarding adjustment for legacy client exit.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide uses a bar chart to show year-over-year growth in Adjusted EBITDA and lists key operational drivers.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
IBEX | Results Presentation Deck | 25 slidesIBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · Action1 hit
16
IBEX | Results Presentation Deck | 25 slidesIBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · Action1 hit
21
The slide includes a legend mapping specific adjustments (A, B, C, D) to their descriptions.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations 1 hit
13
The slide uses a combination of a biological mechanism diagram, a checklist of target criteria, and histological images to validate the therapeutic target.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Solution1 hit
16
The slide uses a table to compare patient demographics and clinical characteristics across different cancer types, specifically focusing on the sufficiency of the melanoma cohort for further development.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
22
Data cut-off Sep 30, 2023. Includes extensive footnotes regarding methodology and specific patient cases.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
24
The slide uses a matrix structure to define the patient population and market opportunity.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
26
The slide uses a biological diagram to illustrate the synergy between CD4 and CD8 T cells in inducing tumor cell death.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
28
Includes specific clinical details on Grade 3/4 events for two patients in the highest dose cohort (DL4b).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
29
Data cut-off Sep 30, 2023. Slide 29.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
37
The table uses a multi-step funnel approach to arrive at the final patient population count.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
42
The slide outlines a manufacturing process for off-the-shelf cell therapy.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
43
The slide uses a bulleted list to define the therapeutic rationale and two line charts to provide empirical evidence.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Loop · Why Now1 hit
50
The slide uses a horizontal arrow-based process flow to categorize programs by development stage (Clinical vs Preclinical).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
53
The slide illustrates the methodology for PK analysis (injection, sampling, quantification) and presents the resulting concentration-time curve.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
55
The slide uses four dose-response curves to show cytotoxicity against different target copy numbers.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
56
The chart uses a broken x-axis between -29 and 0. The legend indicates four distinct treatment groups.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
57
The slide uses a log-linear plot to demonstrate drug clearance over time.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
61
The funnel is represented as a series of concentric circles/segments.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit